Sebastian Amigorena, Ph.D.

Sebastian Amigorena, Ph.D.

Information

Affiliation
Institut Curie, Paris

Biography
Sebastian Amigorena obtained his PhD in Paris in 1990. After a 3 years post doc at Yale University, he returned to Paris in 1995 and started an Inserm AVENIR group together with Christian Bonnerot. Today, he is the head of the Immunology Department (INSERM U932, “Cancer Immunity”) at the Curie Institute. Sebastian Amigorena’s main scientific interest overlaps immunology and cell biology. In his graduate and post-doctoral studies, he analyzed the functions of IgG receptors and described the molecular basis of their inhibitory properties. Sebastian Amigorena is today an expert in antigen presentation and cross presentation in dendritic cells. He analyzed dendritic cells’ endocytic and phagocytic pathways and described several unique specializations of both pathways. Sebastian Amigorena and his team also made significant contributions to the analysis of cytotoxic T cells dynamics in vivo, during the initiation of immune responses in lymph nodes and during the invasion and rejection of solid tumors. More recently, he has contributed to understanding the epigenetic programing of T cell memory. Today, the team studies transposable elements, the regulation of their expression and their roles in anti-tumor immunity.

Speaker on

Cell therapy against cancer | Dr. Yuki Kagoya - Dr. Sebastian Amigorena

Webinar
03/10/2022 | 09:00 - 11:00 (GMT+01:00) Paris

Speaker on

Cell therapy against cancer | Dr. Yuki Kagoya - Dr. Sebastian Amigorena

Webinar
03/10/2022 | 09:00 - 11:00 (GMT+01:00) Paris

This site uses cookies to optimize the functioning of the platform and to measure and target our advertising campaigns.